慢性肾脏病对腹主动脉瘤修复术后结局的影响
基于血管质量倡议(Vascular Quality Initiative)2003年1月至2020年9月数据,分析53867例择期肾下腹主动脉瘤修复患者,按慢性肾脏病(CKD)分期和透析状态分层。无论开放修复(OAR)还是腔内修复(EVAR),CKD严重程度均是围手术期和1年死亡率的预测因素;CKD 4-5期及终末期肾病患者开放修复围手术期死亡风险高。
要点
- CKD 1-2期患者术后1年生存率最高,CKD分期恶化与1年生存率下降独立相关。
- EVAR后CKD 3b期HR 1.74、CKD 4-5期HR 3.23、透析HR 4.48,均与1年生存率下降独立相关。
- OAR后CKD 3b期HR 1.60、CKD 4-5期HR 2.85、透析HR 3.79,均与1年生存率下降独立相关。
核心结论
- 无论采用哪种治疗方式,CKD严重程度均是肾下腹主动脉瘤修复术后围手术期和1年死亡率的重要预测因素,可能反映CKD的自然病史。
- CKD 4-5期及终末期肾病患者开放修复围手术期死亡风险高。
- 肾小球滤过率低于45的患者个体化决策尤为重要,作者认为或许应考虑提高这些患者择期腹主动脉瘤修复的阈值。
- 作者认为可能需要进一步研究这些患者适宜的修复尺寸阈值。
研究设计与样本
- 回顾性分析血管质量倡议(Vascular Quality Initiative)数据库中2003年1月至2020年9月所有接受择期肾下开放腹主动脉瘤修复(OAR)和腔内主动脉修复(EVAR)且术前肾功能数据完整的患者。
- 共纳入53867例择期腹主动脉瘤修复,其中OAR 5396例(10%),EVAR 48471例(90%)。
- 患者按CKD分期分为CKD 1-2期、CKD 3a期、CKD 3b期、CKD 4-5期和透析组。
- 主要结局为围手术期死亡率和1年死亡率,采用Cox多因素回归模型识别生存预测因素。
主要发现
- 大多数患者为白人(90%)和男性(81%),平均年龄73±9岁。
- EVAR患者年龄更大且合并症更多。
- 择期EVAR用于腹主动脉瘤的比例从2003年的52%增至2020年的91%(P < .001)。
- OAR队列围手术期并发症和短期死亡率更高。
- CKD 1-2期组在OAR和EVAR后1年生存率均高于其他组。
关键数值与推荐
- EVAR后,以CKD 1-2期为参照,CKD 3a期HR 1.25(95%CI 0.93-1.68,P = .13);CKD 3b期HR 1.74(95%CI 1.23-2.45,P < .050);CKD 4-5期HR 3.23(95%CI 2.13-4.88,P < .001);透析HR 4.48(95%CI 1.90-10.6,P < .001),均与1年生存率下降独立相关。
- OAR后,以CKD 1-2期为参照,CKD 3a期HR 1.08(95%CI 0.96-1.20,P = .20);CKD 3b期HR 1.60(95%CI 1.41-1.81,P < .001);CKD 4-5期HR 2.85(95%CI 2.39-3.41,P < .001);透析HR 3.79(95%CI 3.01-4.76,P < .001),均与1年生存率下降独立相关。
临床怎么用
- 作者认为肾小球滤过率低于45的患者个体化决策尤为重要,或许应考虑提高这些患者择期腹主动脉瘤修复的阈值。
- 作者认为可能需要进一步研究这些患者适宜的修复尺寸阈值。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Chronic kidney disease (CKD) and end-stage renal disease are traditionally associated with worse outcomes after endovascular and open repair of abdominal aortic aneurysm (AAA). This study stratifies outcomes of AAA repair by approach, CKD severity, and dialysis dependence. METHODS: All patients undergoing elective infrarenal open aneurysm repair (OAR) and endovascular aortic repair (EVAR) with preoperative renal function data captured by the Vascular Quality Initiative between January 2003 and September 2020 were analyzed. Patients were stratified by CKD class as follows: CKD stages 1 and 2, CKD stage 3a, CKD stage 3b, CKD stages 4 and 5, and dialysis. Primary outcomes were perioperative and 1-year mortality. Predictors of survival were identified by Cox multivariate regression models. RESULTS: In total, 53,867 elective AAA repairs were identified: 5396 (10%) OARs and 48,471 (90%) EVARs. Most patients were White (90%) and male (81%), with a mean age of 73 ± 9 years. Patients who underwent EVAR were older and had more comorbidities. The use of elective EVAR for AAA increased from 52% in 2003 to 91% in 2020 (P < .001). The OAR cohort had more perioperative complications and short-term mortality. The CKD 1 and 2 group had the highest 1-year survival compared with the other groups after both OAR and EVAR. On Cox regression analysis, after EVAR, compared with CKD 1 and 2, worsening CKD stage (CKD 3a: hazard ratio [HR], 1.25; 95% confidence interval [CI], 0.93-1.68; P = .13; CKD 3b: HR, 1.74; 95% CI, 1.23-2.45; P < .050; CKD 4-5: HR, 3.23; 95% CI, 2.13-4.88; P < .001), and dialysis (HR, 4.48; 95% CI, 1.90-10.6; P < .001) were independently associated with worse 1-year survival rates. After OAR, compared with CKD 1 and 2, worsening CKD stage (CKD 3a: HR, 1.08; 95% CI, 0.96-1.20; P = .20; CKD 3b: HR, 1.60; 95% CI, 1.41-1.81; P < .001; CKD 4-5: HR, 2.85; 95% CI, 2.39-3.41; P < .001), and dialysis (HR, 3.79; 95% CI, 3.01-4.76; P < .001) were independently associated with worse 1-year survival rates. CONCLUSIONS: Regardless of the treatment approach, CKD severity is an important predictor of perioperative and 1-year mortality rates after infrarenal AAA repair and may reflect the natural history of CKD. Open repair is associated with high perioperative mortality risk in patients with CKD stages 4 and 5, as well as end-stage renal disease. Individualization of patient decision-making is especially important in patients with a glomerular filtration rate of less than 45 and perhaps consideration should be given to raising the threshold for elective AAA repair in these patients. Further studies focusing on appropriate size threshold for repair in these patients may be warranted.
引用
- Pizano A, Scott CK, Porras-Colon J, et al. Chronic kidney disease impacts outcomes after abdominal aortic aneurysm repair. J Vasc Surg. 2022. PMID: 36100032. doi:10.1016/j.jvs.2022.09.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。